Research Report on Global and China Human Vaccine Industry, 2013-2017

Publisher Name :
Date: 01-Aug-2013
No. of pages: 50

The research object of the report is human vaccines. According to different types and sources, vaccines can be divided into pathogenic protein vaccine, recombinant protein vaccines, immune protein vaccines and gene vaccines.

In China, vaccines are generally divided into Vaccine I and Vaccine II. Vaccine I is offered for free, and it's priced and purchased uniformly by the government, covering the major epidemic diseases of Hepatitis B, epidemic cerebrospinal meningitis, Tetanus, etc. Vaccine II is other vaccines inoculated voluntarily at residents' own expense. It is independently priced and has large profit margins, but there are intense competition in the market. The frequently-used Vaccine II includes Pneumonia vaccine, Varicella Vaccine, Type B Haemophilus Influenzae Conjugate Vaccine, Influenza Vaccine, Rabies Vaccine and so on. In China, Vaccine I market are occupied by state-owned enterprises, while foreign-funded enterprises and private enterprises have certain advantages in Vaccine II market.

In 2012, the scale of Chinese vaccine market was about CNY 19 billion, while the scale of pharmaceutical industry was about CNY 1.78 trillion in the same period. The sales revenue of Chinese vaccine industry was only about 1% of that of the pharmaceutical industry far below the global average level of 3%, estimated by CRI. There is still much space for growth. China has the largest population in the world with 10 million newborns yearly. Meanwhile, the aging of the society is increasingly serious. With the economic development and increasingly frequent population immigrations, it inevitably widens the spreading range and increases the speed of disease spreading. Accordingly, new epidemic diseases (Avian Influenza, Influenza A H1N1 and so on) occur frequently.

Data from China's Ministry of Health shows, in 2012, China reported 3,216,900 cases of Class A and B infectious diseases, with16,721 dead. The reported incidence of Class A, B infectious diseases is 238.76/0.1million and the death rate is 1.24/0.1million. In 2012, China reported 3,734,500 cases of Class C infectious diseases, with 594 dead. The reported incidence of Class C infectious diseases is 277.18/0.1million and the death rate is 0.04/0.1 million. China's infectious disease incidence reflects a growing trend comparing with that in previous years, which gradually prompts government's attention on prevention and control of infectious diseases and planned immunization coverage is expanding; public awareness of vaccination is also increasing continuously which promotes the growth of vaccine market.

In China, there are over 30 human vaccine manufacturing enterprises with annual production of over 1 billion including about 40 kinds of vaccines against more than 20 kinds of viruses. With years of technological accumulation, some private vaccine enterprises make big breakthrough in the technical fields and Vaccine II market.

The great potential demand of China's human vaccine market attract many leading enterprises of international vaccine industry to speed up the layout in China. In 2008, Sanofi Pasteur invested USD 94 million to build vaccine factories in Shenzhen. In 2009, Novartis bought 85% of shares of Zhejiang Tianhua Co., Ltd. at the cost of USD 125 million which was approved in March 2011. In May 2011, GSK ended the cooperation with Watson Biological Company; in June it bought 51% shares of Haiwang Yingtelong Biotechnology Co., Ltd. at the cost of GBP 24 million and established wholly-owned subsidiary company. In September 2011, GlaxoSmithKline signed contracts with Sinopharm, Shanghai Zuellig Pharmaceutical Co., Ltd. and Beijing Keyuan Pharmaceutical Co., Ltd. The three distributors are responsible for the business of North China, Central China and South China respectively and provide services for customers through the cold chain logistics system covering all over the country.

CRI forecasts that China vaccine market will maintain a rapid growth in the future years, but the competition will be fiercer. Some less competitive enterprises will go bankrupt or be merged and reorganized, and the concentration rate of vaccine market will rise continually.

Due to the low vaccination rate in China, there's much space for future growth. With the increase of China's income per capita, residents' health awareness and their ability to pay, the vaccine market will get more opportunities and shares.

More following information can be acquired through this report:


  • Vaccine Industry of China and the World

  • Government Policies on China Vaccine Industry

  • Competition in China Vaccine Market

  • Major Segmentation of China Vaccine Market

  • Development Trend of China Vaccine Market


Following people are recommended to buy this report:

  • Vaccine Manufacturers

  • Vaccine Distributors

  • Research Institutions and Investors Focusing on Vaccine Industry

Research Report on Global and China Human Vaccine Industry, 2013-2017

Table of Contents

Chapter 1 Basic Concept of Human Vaccine Industry
1.1 Definition
1.2 Development Course of Vaccines
1.3 Classification of Vaccines
1.4 Necessity of Vaccination

Chapter 2 Analysis on Global Vaccine Market, 2008-2012
2.1 Scale and Structure of Global Vaccine Market
2.1.1 Scale of Global Vaccine Market
2.1.2 Major Application Groups of Vaccines
2.1.3 Structure of Global Vaccine Market
2.2 Vaccines for Children
2.2.1 Major Varieties
2.2.2 Market Scale of Vaccines for Children
2.3 Vaccines for Adults
2.3.1 Varieties of Vaccines for Adults
2.3.2 Market Scale of Vaccines for Adults

Chapter 3 Development Environment of China Vaccine Industry, 2012-2013
3.1 Economic Environment
3.2 Policy Environment
3.2.1 History of China's Immunization Program
3.2.2 Procedure of Immunization Program
3.3 Relevant Legislation and Criterion of China Vaccine Industry
3.3.1 Research and Registration Stage
3.3.2 Production Stage
3.2.3 Circulation Stage
3.3.4 Supporting Policies of Chinese Government on Vaccine Industry

Chapter 4 Analysis on China's Human Vaccine Market, 2008-2012
4.1 Classification of Vaccines in China
4.2 Scale of China Vaccine Market
4.2.1 Overview
4.2.2 Structure of China Vaccine Market
4.3 Segmentation of China Vaccine Market
4.3.1 Vaccine I Market
4.3.2 Vaccine II Market
4.4 Analysis on Major Vaccines in China
4.4.1 Bacillus Calmette-Guerin
4.4.2 Poliomyelitis Vaccine
4.4.3 Measles-Mump-Rubella Vaccine
4.4.4 Diphtheria and Tetanus (DTP or DTaP) Vaccine
4.4.5 Encephalitis Vaccine
4.4.6 Meningococcus Vaccine
4.4.7 Human Rabies Vaccine
4.4.8 Type B Haemophilus Influenzae Conjugate Vaccine
4.4.9 Influenza Vaccine
4.4.10 Varicella Vaccine
4.4.11 Hepatitis A Vaccine
4.4.12 Pneumococcus Vaccine
4.4.13 Hepatitis B Vaccine

Chapter 5 China's Major Vaccine Manufacturers
5.1 China National Biotec Group (CNBG)
5.1.1 Overview
5.1.2 Subordinate Biological Products Institutions
5.2 Hualan Biological Engineering Co., Ltd.
5.3 Beijing Tiantan Biological Products Co., Ltd.
5.4 Changchun High-Tech Industry (Group) Co., Ltd.
5.5 Haiwang Yingtelong Biotechnology Co., Ltd.
5.6 Other Enterprises

Chapter 6 Prediction on Development of China Vaccine Industry
6.1 Prediction on Supply and Demand
6.1.1 Prediction on Production
6.1.2 Prediction on Market Scale
6.2 Prediction on Development Trend
6.2.1 Technology Trend
6.2.2 Market Trend
6.2.3 Competition Trend

List of Charts

Chart Introduction on Basic Ingredients of Vaccines
Chart Classification of Human Vaccines
Chart Comparison Between Traditional and New Vaccines
Chart Scale of Global Vaccine Market, 2004-2012
Chart Introduction on Major Vaccines in the World
Chart Major Varieties of Pneumonia Vaccines in the World
Chart Major Hepatitis Vaccines in Global Market
Chart World's Major Infectious Diseases Since the 21st century
Chart Market Scale of China Vaccine Industry, 2005-2012
Chart Lot Release Quantity of BCG Vaccine in China, 2010-2012
Chart Market Scale of MMR Vaccine in China, 2010-2012
Chart Lot Release Quantity of Human Rabies Vaccine in China, 2010-2012
Chart Lot Release Quantity of Influenza Vaccine in China, 2010-2012
Chart Prediction on Market Scale of China Vaccine Industry, 2013-2017
Chart Immunization Program Procedure for Chinese Children
Chart Circulation of Vaccines in China
Chart Prediction of China Vaccine Market Scale, 2013-2017

  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • Surgical Robots Market 2016 Updates on Companies, Products and More
    Surgical robots are medical devices that assist surgeons in performing many types of complex procedures with more accuracy, flexibility and control than is possible with conventional techniques. The aim of surgical robots market players is to provide improved diagnostic skills, a less invasive and more comfortable experience for the patient, and the ability to do [...]
  • International Wound Cleanser Industry 2019 Forecasts with Feasibility Study of Future Projects
    ‘Market Research Report on Global and Chinese Wound Cleanser Industry, 2009-2019’ is a comprehensive market research report that offers top-notch industry insights and analyzes the growth prospects of the industry, along with evaluating the up-surging opportunities in the Global and Chinese market over the forecast period of 2014-2019. The methodically planned sections of the research [...]
  • Global Analgesics Market 2016-2020
    Published: 17-Jun-2016        Price: US 2500 Onwards        Pages: 102
    Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or i......
  • COPD Drugs Market in China 2016-2020
    Published: 17-Jun-2016        Price: US 2500 Onwards        Pages: 74
    Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not understood, but most cases are caused due to genetic factors and by inhaling pollutants, including smoke, fumes, and chemicals. As the disease develops, the symptoms tend to......
  • United States Botanical Drug Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 3800 Onwards        Pages: 138
    The United States Botanical Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Botanical Drug industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Botanical Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. ......
  • United States Histone Deacetylase Inhibitors Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 3800 Onwards        Pages: 138
    The United States Histone Deacetylase Inhibitors Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Histone Deacetylase Inhibitors industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Histone Deacetylase Inhibitors market analysis is provided for the United States markets including development trends, competitive landscape analysis, an......
  • United States Hyperphosphatemia Drug Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 3800 Onwards        Pages: 137
    The United States Hyperphosphatemia Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Hyperphosphatemia Drug industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hyperphosphatemia Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions developmen......
  • Global Antibody Drug Conjugates Consumption 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 4000 Onwards        Pages: 157
    The Global Antibody Drug Conjugates Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Antibody Drug Conjugates market. First, the report provides a basic overview of the Antibody Drug Conjugates industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report st......
  • Global Cholesterol-Lowering Drug Consumption 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 4000 Onwards        Pages: 158
    The Global Cholesterol-Lowering Drug Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Cholesterol-Lowering Drug market. First, the report provides a basic overview of the Cholesterol-Lowering Drug industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report......
  • Global Hyperphosphatemia Drugs Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 2800 Onwards        Pages: 154
    The Global Hyperphosphatemia Drugs Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Hyperphosphatemia Drugs industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hyperphosphatemia Drugs market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' de......
  • Global Measles, Mumps and Rubella Combined Vaccine, Live Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 2800 Onwards        Pages: 152
    The Global Measles, Mumps and Rubella Combined Vaccine, Live Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Measles, Mumps and Rubella Combined Vaccine, Live industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Measles, Mumps and Rubella Combined Vaccine, Live market analysis is provided for the international market includ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs